be_ixf;ym_202409 d_30; ct_50

Latest Insights on GRAB

omicron Adagio Therapeutics A Stock-Picking Mutation to Beat the Omicron Threat This is a company that has never made a profit. In fact, it’s never made any money at all. On top of that, analysts expect its per-share losses to double by the end of 2022. Assuming Adagio manages to generate some revenues next year — the market consensus is a minuscule $151 million — it’s already trading at almost 20 times those sales. Why? Because COVID is here to stay … and the search for a response is moving into new areas … quickly.
2022 stock predictions 5 Bold Predictions for 2022 and Beyond These will be the biggest growth themes for 2022.
Unusual Options Activity: $1.3 Million on 3 Quick Rebounds Unusual Options Activity: $1.3 Million on 3 Quick Rebounds Big Money is buying the dip in this round of Chad's Unusual Options Activity. Over $1.3 million is riding on rebounds in PLAN, UNG, and FB.
Bitcoin hoarders hodlers Coinbase Smaug meme small You’re Way Off Coinbase; DoorDash’s Fundamental Failure & Fubo’s FUBAR
by Joseph Hargett November 10, 2021 Great Stuff
Bitcoin Hoarding Sinks Coinbase? Great Ones, Coinbase Global (Nasdaq: ) had the crypto world in an uproar today. Well … part of the crypto world, that is. As you probably already know, Coinbase is the world’s second-largest cryptocurrency exchange, averaging more than $8 billion in crypto volume per day. That’s still a far cry from […]
3d-printing Join the 3D-Printing Boom With This ETF If you aren’t investing in 3D-printing stocks right now, you’re missing the boat.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“I started with $215,000 in Nov. 2018, It is now over 800,000. So very happy with Banyan Hill Publishing.”

- Larry K.

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

“Loving this. Should have started a long time ago.”

- Jay

Share This